Concept

Alzheimer's disease

Related publications (197)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Alzheimer's disease

Graph Chatbot

Chat with Graph Search

Notch signaling promotes disease initiation and progression in murine chronic lymphocytic leukemia

Altered cortical thickness development in 22q11.2 deletion syndrome and association with psychotic symptoms

Reverse engineering Lewy bodies: how far have we come and how far can we go?

A New Chemoenzymatic Semisynthetic Approach Provides Insight into the Role of Phosphorylation beyond Exon1 of Huntingtin and Reveals N-Terminal Fragment Length-Dependent Distinct Mechanisms of Aggregation

Anti-Aβ antibodies bound to neuritic plaques enhance microglia activity and mitigate tau pathology

Diffusion MRI biomarkers of white matter microstructure vary nonmonotonically with increasing cerebral amyloid deposition

Discovery of 2-(4-(2-fluoroethoxy)piperidin-1-yl)-9-methyl-9H-pyrrolo[2,3-b:4,5-c']dipyridine ([18F]PI-2014) as PET tracer for the detection of pathological aggregated tau in Alzheimer's disease and other tauopathies

Unraveling the complexity of amyloid polymorphism using gold nanoparticles and cryo-EM

Phosphorylation of the overlooked tyrosine 310 regulates the structure, aggregation, and microtubule- and lipid-binding properties of Tau

Half a century of amyloids: past, present and future